Skip to content

CBJ

FinoTraze Unveiled: FinoTraze Emerges as 2025’s Most Trusted AI Trading Solution for Smarter Investing with Precision

New York City, NY, Nov. 15, 2025 (GLOBE NEWSWIRE) — What Is FinoTraze? – Inside the AI Trading Platform Making
Read More

Linamar Completes Acquisition of Aludyne North America Assets

GUELPH, Ontario, Nov. 15, 2025 (GLOBE NEWSWIRE) — Linamar Corporation (TSX:LNR) today announced that its previously announced acquisition of select
Read More

Algernon Closes First Tranche of its Recently Announced Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE
Read More

Rio Silver Announces Grant of Stock Options

VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) — Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC:
Read More

Indigenous Partnerships Success Showcase (IPSS) Honours 2025 Shared Prosperity Award Recipients

VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) — The Indigenous Partnerships Success Showcase (IPSS) celebrated outstanding leadership, partnership, and
Read More

Aberdeen Announces Management Addition

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB, F:A8H, OTC:AABVF) is pleased to
Read More

Consolidated Lithium Metals Announces Closing Of Life Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 14, 2025 (GLOBE
Read More

Avicanna Reports Q3 2025

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical
Read More

Dundee Corporation Extends Strong Investment Performance and Growing Royalty Revenue in Q3

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) — “This quarter, we delivered strong net earnings that reflected the first full quarter
Read More

COSCIENS Biopharma Inc. Announces Leadership Change

TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a
Read More